Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 154 Total
SPRB - Spruce Biosciences Inc - Stock Price Chart
TickerSPRB [NASD]
CompanySpruce Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap13.46MEPS (ttm)-0.96
P/E-EPS this Y24.68%
Forward P/E-EPS next Y38.97%
PEG-EPS past 5Y-22.95%
P/S1.90EPS next 5Y20.77%
P/B0.26EPS Q/Q30.84%
Dividend-Sales Q/Q-80.41%
Insider Own30.86%Inst Own23.54%
Insider Trans0.00%Inst Trans-8.16%
Short Float1.49%EarningsNov 11/b
Analyst Recom3.00Target Price1.01
Avg Volume415.31K52W Range0.32 - 0.87
Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. It focuses on developing its wholly owned product candidate, Tildacerfont. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Charlton Ralph William IIICHIEF MEDICAL OFFICERDec 10 '24Option Exercise0.00106,4000161,773Dec 20 08:30 PM
Charlton Ralph William IIICHIEF MEDICAL OFFICERDec 16 '24Option Exercise0.0058,3500172,668Dec 20 08:30 PM
Gharib Samir M.PRESIDENT AND CFODec 10 '24Option Exercise0.00154,0000356,776Dec 20 08:28 PM
Gharib Samir M.PRESIDENT AND CFODec 16 '24Option Exercise0.0075,7500363,841Dec 20 08:28 PM
Szwarcberg Javier B.CHIEF EXECUTIVE OFFICERDec 16 '24Option Exercise0.00200,7000506,796Dec 20 08:28 PM
CNEY - CN Energy Group Inc - Stock Price Chart
TickerCNEY [NASD]
CompanyCN Energy Group Inc
CountryChina
IndustrySpecialty Chemicals
Market Cap1.17MEPS (ttm)-3.24
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.02EPS next 5Y-
P/B0.01EPS Q/Q-163.06%
Dividend-Sales Q/Q-44.15%
Insider Own4.77%Inst Own3.21%
Insider Trans0.00%Inst Trans0.19%
Short Float7.29%Earnings-
Analyst Recom1.00Target Price36.00
Avg Volume3.48M52W Range0.16 - 1.60
CN Energy Group, Inc. is a holding company, which engages in the manufacture and supply of wood-based activated carbon and production of biomass electricity in the process of producing activated carbon. The company was founded on November 23, 2018 and is headquartered in Lishui City, China.
AGRI - AgriFORCE Growing Systems ltd - Stock Price Chart
TickerAGRI [NASD]
CompanyAgriFORCE Growing Systems ltd
CountryCanada
IndustryFarm Products
Market Cap2.39MEPS (ttm)-1.10
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-126.21%
P/S39.88EPS next 5Y-
P/B20.85EPS Q/Q21.22%
Dividend-Sales Q/Q-
Insider Own0.49%Inst Own2.21%
Insider Trans0.00%Inst Trans0.03%
Short Float5.67%Earnings-
Analyst Recom1.00Target Price10000.00
Avg Volume148.51K52W Range1.35 - 22.39
AgriFORCE Growing Systems Ltd. is an agriculture technology company, which engages in the development and utilization of intellectual property (IP) assets for improvement. Its solutions include consulting, air and surface sterilization, and other projects. The company was founded on December 22, 2017 and is headquartered in Vancouver, Canada.
ACIU - AC Immune SA - Stock Price Chart
TickerACIU [NASD]
CompanyAC Immune SA
CountrySwitzerland
IndustryBiotechnology
Market Cap221.63MEPS (ttm)-0.45
P/E-EPS this Y-9.59%
Forward P/E-EPS next Y-27.89%
PEG-EPS past 5Y3.28%
P/S4.73EPS next 5Y-
P/B1.29EPS Q/Q131.14%
Dividend-Sales Q/Q-
Insider Own37.89%Inst Own27.63%
Insider Trans0.00%Inst Trans-8.92%
Short Float1.76%EarningsMar 13/b
Analyst Recom1.00Target Price10.07
Avg Volume178.47K52W Range2.19 - 4.98
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREA M. A PFEIFEROfficerSep 27 '24Proposed Sale3.7040,000148,000Sep 27 04:26 PM
ANDREA M. A PFEIFEROfficerSep 18 '24Proposed Sale3.4620,00069,200Sep 18 04:40 PM
CRBP - Corbus Pharmaceuticals Holdings Inc - Stock Price Chart
TickerCRBP [NASD, RUT]
CompanyCorbus Pharmaceuticals Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap77.43MEPS (ttm)-3.66
P/E-EPS this Y-35.82%
Forward P/E-EPS next Y3.14%
PEG-EPS past 5Y35.71%
P/S-EPS next 5Y-15.65%
P/B0.54EPS Q/Q56.85%
Dividend-Sales Q/Q-
Insider Own13.56%Inst Own89.48%
Insider Trans25.18%Inst Trans-10.67%
Short Float22.98%EarningsMar 11/b
Analyst Recom1.00Target Price52.11
Avg Volume254.14K52W Range6.38 - 61.90
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. The company was founded in April 2009 and is headquartered in Norwood, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smethurst DominicChief Medical OfficerMar 06 '25Sale6.786,39343,33070,807Mar 07 04:30 PM
Smethurst DominicOfficerMar 06 '25Proposed Sale6.846,39343,728Mar 06 04:03 PM
Moran Sean F.Chief Financial OfficerFeb 14 '25Sale8.762,79224,44673,313Feb 18 05:40 PM
Cohen YuvalChief Executive OfficerFeb 14 '25Sale8.767,13462,465138,187Feb 18 05:40 PM
Moran Sean F.OfficerFeb 14 '25Proposed Sale9.482,79226,468Feb 14 04:18 PM
AMR - Alpha Metallurgical Resources Inc - Stock Price Chart
TickerAMR [NYSE, RUT]
CompanyAlpha Metallurgical Resources Inc
CountryUSA
IndustryCoking Coal
Market Cap1.70BEPS (ttm)14.21
P/E9.14EPS this Y21.37%
Forward P/E4.00EPS next Y81.03%
PEG0.57EPS past 5Y-
P/S0.57EPS next 5Y15.97%
P/B1.03EPS Q/Q-101.27%
Dividend-Sales Q/Q-35.69%
Insider Own16.54%Inst Own87.49%
Insider Trans-0.49%Inst Trans2.63%
Short Float10.90%EarningsFeb 28/b
Analyst Recom2.33Target Price272.00
Avg Volume259.96K52W Range125.81 - 361.17
Alpha Metallurgical Resources, Inc. is a mining company. It engages in the provision of met and thermal coal. The firm operates through the following business segments: Met, CAPP-Thermal, and All Other. The Met segment consists of met coal mines, including Deep Mine 41, Road Fork 52, Black Eagle, and Lynn Branch. The CAPP-Thermal segment consists of underground thermal coal mine. The All Other segment includes general corporate overhead and corporate assets and liabilities, elimination of intersegment activity, and discontinued operations. The company was founded on June 26, 2016 and is headquartered in Bristol, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Courtis Kenneth S.DirectorDec 13 '24Sale228.7310,6212,429,301603,342Dec 17 07:40 PM
Nicholson Roger LeeCAO, GC & SecretaryMay 14 '24Sale290.163,5931,042,5506,127May 15 04:36 PM
DIBS - 1stdibs.com Inc - Stock Price Chart
TickerDIBS [NASD, RUT]
Company1stdibs.com Inc
CountryUSA
IndustryInternet Retail
Market Cap106.91MEPS (ttm)-0.50
P/E-EPS this Y-24.49%
Forward P/E-EPS next Y1.64%
PEG-EPS past 5Y15.80%
P/S1.21EPS next 5Y-
P/B1.09EPS Q/Q-94.84%
Dividend-Sales Q/Q8.83%
Insider Own29.54%Inst Own40.85%
Insider Trans-0.30%Inst Trans15.28%
Short Float1.89%EarningsFeb 28/b
Analyst Recom1.67Target Price8.00
Avg Volume84.72K52W Range2.87 - 6.25
1stdibs.com, Inc. operates as an online marketplace for home decorations, fashion, and interior design. Its business units include 1stdibs and Design Manager. It offers vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The company was founded by Michael Bruno and Laurence Forcione in 2000 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rubinger MatthewOfficerMar 18 '25Proposed Sale3.008,13224,436Mar 18 04:57 PM
Rubinger MatthewChief Commercial OfficerDec 18 '24Sale3.608,13329,29026,030Mar 12 08:54 PM
Rubinger MatthewOfficerDec 18 '24Proposed Sale3.608,13329,290Dec 18 04:18 PM
Rubinger MatthewChief Commercial OfficerNov 22 '24Sale3.9412,00247,29012,477Nov 26 06:08 PM
Rubinger MatthewOfficerNov 22 '24Proposed Sale3.9412,00247,290Nov 22 03:23 PM
SKYE - Skye Bioscience Inc - Stock Price Chart
TickerSKYE [NASD, RUT]
CompanySkye Bioscience Inc
CountryUSA
IndustryBiotechnology
Market Cap69.48MEPS (ttm)-0.84
P/E-EPS this Y83.96%
Forward P/E-EPS next Y-30.81%
PEG-EPS past 5Y32.94%
P/S-EPS next 5Y36.51%
P/B0.92EPS Q/Q96.83%
Dividend-Sales Q/Q-
Insider Own42.09%Inst Own43.95%
Insider Trans-1.79%Inst Trans-5.57%
Short Float12.33%EarningsMar 20/a
Analyst Recom1.00Target Price18.00
Avg Volume172.22K52W Range2.31 - 17.65
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Diep Tuan TuChief Development OfficerNov 18 '24Sale4.9919,48997,25082,259Nov 20 08:23 AM
Diep Tuan TuChief Development OfficerNov 15 '24Sale5.5585472101,748Nov 20 08:23 AM
ARSENAULT KAITLYNChief Financial OfficerNov 18 '24Sale4.9943,206215,598166,342Nov 19 09:57 PM
ARSENAULT KAITLYNChief Financial OfficerNov 15 '24Sale5.551901,054209,548Nov 19 09:57 PM
DHILLON PUNITChief Executive OfficerNov 18 '24Sale4.9982,546411,905329,823Nov 19 09:20 PM
ASMB - Assembly Biosciences Inc - Stock Price Chart
TickerASMB [NASD]
CompanyAssembly Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap71.57MEPS (ttm)-7.14
P/E-EPS this Y49.51%
Forward P/E-EPS next Y-9.10%
PEG-EPS past 5Y22.47%
P/S2.53EPS next 5Y22.47%
P/B2.75EPS Q/Q54.02%
Dividend-Sales Q/Q-
Insider Own47.32%Inst Own15.36%
Insider Trans48.20%Inst Trans10.00%
Short Float0.61%EarningsNov 07/a
Analyst Recom2.00Target Price36.00
Avg Volume29.28K52W Range10.45 - 19.93
Mar-04-25 08:34PM Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently? (Insider Monkey)
Feb-26-25 08:00AM Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus (GlobeNewswire) +7.86%
Feb-20-25 08:00AM Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes (GlobeNewswire)
Dec-29-24 03:00AM Gilead Buys $20.1 Million of Assembly Biosciences Stock (Barrons.com)
Dec-26-24 08:00AM Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B (GlobeNewswire)
Dec-19-24 08:00AM Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs (GlobeNewswire) +17.02%
Nov-07-24 06:19PM Assembly Biosciences: Q3 Earnings Snapshot (Associated Press Finance) +5.11%
04:05PM Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates (GlobeNewswire)
Sep-23-24 01:39PM Assembly Biosciences' Investigational Herpes Treatment Shows Safety In Healthy Participants (UPDATED) (Benzinga) -16.31%
08:00AM Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 (GlobeNewswire)
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Houghton MichaelDirectorDec 30 '24Buy15.613,20249,9983,202Dec 31 04:24 PM
GILEAD SCIENCES, INC.10% OwnerDec 19 '24Buy21.37940,49920,098,4642,209,471Dec 23 08:26 PM
Schornstein Alexander10% OwnerNov 22 '24Buy14.8717,024253,104720,137Nov 26 09:15 AM
Schornstein Alexander10% OwnerNov 25 '24Buy14.917,976118,890728,113Nov 26 09:15 AM
White Nicole SChief Manufacturing OfficerNov 18 '24Sale16.294065211,871Nov 19 04:05 PM
FLWS - 1-800 Flowers.com Inc - Stock Price Chart
TickerFLWS [NASD, RUT]
Company1-800 Flowers.com Inc
CountryUSA
IndustrySpecialty Retail
Market Cap352.98MEPS (ttm)-0.12
P/E-EPS this Y-160.00%
Forward P/E45.49EPS next Y212.96%
PEG-EPS past 5Y-
P/S0.20EPS next 5Y3.57%
P/B0.71EPS Q/Q3.67%
Dividend-Sales Q/Q-5.66%
Insider Own57.73%Inst Own52.46%
Insider Trans10.93%Inst Trans29.35%
Short Float27.28%EarningsJan 30/b
Analyst Recom1.67Target Price9.88
Avg Volume679.57K52W Range5.52 - 11.42
1-800-FLOWERS.COM, Inc. engages in the provision of gift design. It operates through the following segments: Consumer Floral and Gifts, BloomNet, Gourmet Foods and Gift Baskets. The Consumer Floral and Gifts segment focuses on the operation of 1-800-Flowers.com, PersonalizationMall, Alice's Table, and Things Remembered. The BloomNet segment includes memberships, service offerings to florists, and other products. The Gourmet Foods and Gift Baskets segment involves the management of Harry & David, Wolferman's, Cheryl's Cookies, The Popcorn Factory, 1-800- Baskets/DesignPac, Shari's Berries, and Vital Choice. The company was founded by James Francis McCann in 1976 and is headquartered in Jericho, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fund 1 Investments, LLC10% OwnerMar 14 '25Buy5.8935,000206,0387,834,469Mar 17 04:44 PM
Fund 1 Investments, LLC10% OwnerMar 13 '25Buy6.0310,00060,3007,799,469Mar 17 04:44 PM
Fund 1 Investments, LLC10% OwnerMar 11 '25Buy6.2825,000157,0987,789,469Mar 12 05:09 PM
Fund 1 Investments, LLC10% OwnerMar 10 '25Buy6.5710,00065,7007,764,469Mar 12 05:09 PM
Fund 1 Investments, LLC10% OwnerMar 06 '25Buy6.5073,500477,8687,731,969Mar 07 04:44 PM
15678910111213141516